1. Home
  2. LVRO vs MLYS Comparison

LVRO vs MLYS Comparison

Compare LVRO & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LVRO
  • MLYS
  • Stock Information
  • Founded
  • LVRO 2017
  • MLYS 2019
  • Country
  • LVRO Brazil
  • MLYS United States
  • Employees
  • LVRO N/A
  • MLYS N/A
  • Industry
  • LVRO Blank Checks
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LVRO Finance
  • MLYS Health Care
  • Exchange
  • LVRO Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • LVRO 387.1M
  • MLYS 634.6M
  • IPO Year
  • LVRO N/A
  • MLYS 2023
  • Fundamental
  • Price
  • LVRO $3.32
  • MLYS $9.24
  • Analyst Decision
  • LVRO Buy
  • MLYS Strong Buy
  • Analyst Count
  • LVRO 3
  • MLYS 2
  • Target Price
  • LVRO $7.17
  • MLYS $30.00
  • AVG Volume (30 Days)
  • LVRO 14.3K
  • MLYS 266.6K
  • Earning Date
  • LVRO 03-06-2025
  • MLYS 11-11-2024
  • Dividend Yield
  • LVRO N/A
  • MLYS N/A
  • EPS Growth
  • LVRO N/A
  • MLYS N/A
  • EPS
  • LVRO N/A
  • MLYS N/A
  • Revenue
  • LVRO $1,691,812,087.00
  • MLYS N/A
  • Revenue This Year
  • LVRO N/A
  • MLYS N/A
  • Revenue Next Year
  • LVRO $12.53
  • MLYS N/A
  • P/E Ratio
  • LVRO N/A
  • MLYS N/A
  • Revenue Growth
  • LVRO 0.48
  • MLYS N/A
  • 52 Week Low
  • LVRO $3.06
  • MLYS $8.28
  • 52 Week High
  • LVRO $8.79
  • MLYS $16.91
  • Technical
  • Relative Strength Index (RSI)
  • LVRO 28.42
  • MLYS 32.12
  • Support Level
  • LVRO $3.06
  • MLYS $8.60
  • Resistance Level
  • LVRO $3.97
  • MLYS $9.97
  • Average True Range (ATR)
  • LVRO 0.43
  • MLYS 0.88
  • MACD
  • LVRO -0.17
  • MLYS -0.31
  • Stochastic Oscillator
  • LVRO 10.24
  • MLYS 13.25

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

Share on Social Networks: